Zusammenfassung
Die Lungenmetastasenchirurgie bietet selbst im Stadium IV mit multiplem und beidseitigem Befall noch bei einer Reihe von malignen Primärtumoren die Möglichkeit der kurativen chirurgischen Behandlung. Da bei jedem dritten Patienten im Laufe der malignen Erkrankung Lungenmetastasen auftreten und bei jedem fünften von diesen Patienten isoliert die Lunge befallen ist, sollte die Indikation wesentlich häufiger im interdisziplinären Tumorboard diskutiert und gestellt werden. Außerdem sollte die Lunge bei malignen extrathorakalen Tumoren mit in die Ausbreitungsdiagnostik eingeschlossen werden und ebenfalls im Follow-up untersucht werden, um synchrone und metachrone Lungenmetastasen rechtzeitig im Therapieschema berücksichtigen zu können. Heutzutage stehen parenchymsparende Resektionstechniken zur Verfügung, wie z. B. die Lasertechnik, die es ermöglicht, komplikationsarm bis über 100 Metastasen pro Patient zu resezieren. Auch bei Patienten mit mehr als 20 und beidseitigen Metastasen sollte die Resektion diskutiert werden, da im Falle von vollständigen Resektionen 5-Jahresüberlebensraten von 20% erreicht werden können.
Abstract
The surgical resection of pulmonary metastases in diverse stage IV malignant tumors with multiple and bilateral lung involvement offers the possibility of curative therapy. Lung metastases occur in 30% of patients with malignant disease; in 20% the spread is limited to the lungs so that the indication for surgical resection should be discussed more often and recommended in interdisciplinary tumor boards. Furthermore to diagnose synchronous and metachronous spread to the lungs early, the lung should be included in follow-up examinations in patients with extrathoracic tumors. Nowadays lung parenchyma-sparing resection methods like the laser technique allow removal of more than 100 metastases per patient. In patients with over 20 metastases and bilateral involvement an operative resection should still be discussed because in these individuals when complete resection is achieved 5-year survival rates of 20% are being reported.
Literatur
Beattie EJ Jr, Harvey JC, Marcove R et al (1991) Results of multiple pulmonary resections for metastatic osteogenic sarcome after two decades. J Surg Oncol 46:154–155
Ercan S, Nichols FC III, Trastek VF et al (2004) Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma. Ann Thorac Surg 77:1786–1791
Fidler IJ (1997) Molecular biology of cancer: Invasion and metastasis. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and practice of oncology. 5th edn, Lippincott-Raven, Philadelphia, pp 135
Friedel G, Pastorino U, Ginsberg RJ et al (2002) On behalf of the International registry of lung metastases, London, England. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases. Eur J Cardiothorac Surg 22:335–344
Harpole DH, Johnson Cm, Wolfe WG et al (1992) Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 103:743–750
Inoue M, Kotake Y, Nakagawa N et al (2002) History of the surgical management of pulmonary metastases and development of the International Registry. Semin Thorac Cardiovasc Surg 14:18.28
Inoue M, Kotake Y, Nakgawa K et al (2000) Surgery for pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 70:280–383
Internullo E, Cassivi D, Van Raemdonck D et al (2008) A survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thoracic Oncol 3:1257–1266
Kondo H, Okumura T, Ohde Y, Nakagawa K (2005) Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes. Int J Clin Oncol 10:81–85
Marcove RC, Mike V, Kajek JV et al (1970) Osteogenic sarcome under the age of 21: A review of 145 operative cases. J Bone Joint Surg Am 52A:411–421
Martini N, Huvos AG, Mike V et al (1971) Multiple pulmonary resections in the treatment of osteogenic sarcome. Ann Thorac Surg 12:271–280
McCormack PM, Bains MS, Begg CB et al (1996) Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 62:213–216
Miller FR (1989) Biology of metastasis. In: Roth JA, Ruckdeschel JC, Weisenburger TH (eds) Thoracic Oncology. WB Saunders, Philadelphia, p 609
Mountain CF, McMurtrey MJ, Hermes KE (1984) Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 38:323–330
Murthy SC, Kim K, Rice TW et al (2005) Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 79:996–1003
Naunheim K (2007) Thoracoscopy versus the open approach for resection of solitary pulmonary metastases. In: Ferguson M (ed) Difficult decisions in thoracic surgery; an evidence-based approach. Springer, Berlin Heidelberg New York, pp 151–157
Patel A, De Camp M (2007) Unilateral or bilateral approach for unilateral pulmonary metastatic disease. In: Ferguson M (ed) Difficult decisions in thoracic surgery: an evidence-based approach. Springer, Berlin Heidelberg New York, pp 158–164
Pfannschmidt J, Muley Th, Hoffmann H, Dienemann H (2003) Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma. Experiences in 167 patients. J Thorac Cardiovasc Surg 126:732–739
Pfannschmidt J (2006) Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 81:448–454
Piltz ST, Meimarakis G, Wichmann MW et al (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73:1082–1087
Robert-Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg) (2008) Krebs in Deutschland 2003–2004. Häufigkeiten und Trends. 6. üb. Aufl., Berlin
Rolle A, Koch R, Alpard SK, Zwischenberger JB (2002) Lobe-sparing resection of multiple pulmonary metastases with a new 1318 nm Nd: YAG laser – first 100 patients. Ann Thorac Surg 74:865–869
Rolle A, Pereszlenyi A, Koch R et al (2006) Is surgery for multiple metastases reasonable? A total of 328 consecutive patients with multiple-laser metastasectomies with a new 1318-nm Nd: YAG laser. J Thorac Cardiovasc Surg 131:1236–1242
Rolle A, Pereszlenyi A (2005) Laser resection of lung metastasis. Multimedia manual of cardiothoracic surgery doi.10.151/mmcts.2004.000570. http://www.mmcts.ctsnetjournals.org/cgi/collections/surgery_metastatic_lung
Schirren J, Wassenberg D, Krysa S et al (1994) Surgery of lung metastasis – indications, results, and prognostic factors as an interdisciplinary concept. Pneumologie 48:469–474
Singletary SE, Walsh G, Vauthey JN et al (2003) A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8:241–251
Tafra L, Dale PS, Wanek LA et al (1995) Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg 110(1):119–129
Tamura M, Oda M, Tsunezuka Y et al (2004) Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: Utility as a prognostic factor. J Thorac Cardiovasc Surg 128:517–522
The International Registry of Lung Metastases (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113:37–49
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung hin: Es besteht eine rein familiäre Beziehung zur Firma Rolle & Rolle GmbH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rolle, A. Chirurgie von pulmonalen Metastasen. Pneumologe 7, 265–271 (2010). https://doi.org/10.1007/s10405-009-0359-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-009-0359-4